← Back to Search

Behavioural Intervention

CICADAS and then PEERS for Autism Spectrum Disorder (CICADAS Trial)

N/A
Waitlist Available
Led By Bruno Biagianti, MD
Research Sponsored by Posit Science Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

CICADAS Trial Summary

This trial is testing an app to help improve social-emotional learning for adolescents on the autism spectrum.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

CICADAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Digital Assessment Completion Rate
NB-SCT Program Adherence
Post-Study Usability Ratings
+2 more

CICADAS Trial Design

3Treatment groups
Experimental Treatment
Group I: Arm CExperimental Treatment1 Intervention
Participants assigned to Arm C will engage in PEERS + Active Comparator for the first 16 weeks of the intervention period. After the completion of the first intervention period and the mid-intervention assessment (V3) visit, these participants will then be assigned to No-Contact (no active intervention) for the second 16 weeks of the intervention period.
Group II: Arm BExperimental Treatment1 Intervention
Participants assigned to Arm B will engage in PEERS + CICADAS for the first 16 weeks of the intervention period. After the completion of the first intervention period and the mid-intervention assessment (V3) visit, these participants will then be assigned to No-Contact (no active intervention) for the second 16 weeks of the intervention period.
Group III: Arm AExperimental Treatment1 Intervention
Participants assigned to Arm A will engage in CICADAS app only for the first 16 weeks of the intervention period. After the completion of the first intervention period and the mid-intervention assessment (V3) visit, these participants will then be assigned to the PEERS only group for the second 16 weeks of the intervention period. Participants will be asked to attend weekly 1-hour group sessions led by a PEERS clinician.

Find a Location

Who is running the clinical trial?

Posit Science CorporationLead Sponsor
38 Previous Clinical Trials
4,140 Total Patients Enrolled
University of MinnesotaOTHER
1,377 Previous Clinical Trials
1,588,229 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
108 Patients Enrolled for Autism Spectrum Disorder
Bruno Biagianti, MDPrincipal InvestigatorPosit Science Corporation
1 Previous Clinical Trials
34 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
University of Minnesota
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Care Improving Cognition for ADolescents on the Autism Spectrum
2021. "Care Improving Cognition for ADolescents on the Autism Spectrum". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04562688.
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top